Traxion Sab De Cv Ord Shs GRPOF

RE:Tetra will be on the move soon enough...

[CookeMonster]

LeafRider wrote: I've watched quite a few LP stocks slip below their marks that were established before the Dec/Jan run. Tetra meanwhile is highlighting what accumulation looks like before a real break out. When Tetra is back upwards of $1 before October 17th on the back of some great pharma partnership announcements and clinical trial news, everyone will finally see the benefits of Tetra working different angles.  Everyone needs to understand that Tetra will be privy to having their preliminary data of the Phase 3 clinical for PPP001. This is information that you'll start to see support a major shareprice move closer to $2 range, which I feel we should be at right now anyway. There are bio-pharma companies that have what Tetra has, but are over the $300 million market cap. The difference is direct ties to the US investment market, and you can be sure that the next big CEO Tetra hires, will be someone with a huge line of connections in US pharma.

We as shareholders won't get any of this preliminary data from the clinical trials, but Tetra will be working the phones / deal side of things with any data they receive from their clinical trials. Tetra has clearly added to the list of connections lately.

The previous capital raise with the bought-deal and private placement was intended to advance clinical trials over their entire product line. Yes that will show that we are "burning cash", but this is part of the business. Anyone telling you otherwise is just give you fear mongering informatoin to cast doubt on your early sound investment on a company that's on the verge of a breakout. If you can't understand that "burn rate" and spending money on "clinical trails" are two totally different things, then you probably don't understand the potential that Tetra has to offer.

You can certainly wait until "positive data is released from the ph. 3 PPP001 study", but at that point with thing will be +$1.20. So you need to say too much risk now is worth giving up 100% on early returns to be more certain when this moves to $1.20+ on the back of the first big announcment made public about the success of Phase 3 clinical trial. Stay sharp people 5-6 months out we could be due for a big run, and maybe even a buyout offer late this year or into next year. Acquiring the first smokable cannabis DIN# is probably at the top of the list of many companies out there. Thinking we won't be sold, is a mistake, sure if we had 10's of millions in revenues I'd be more certain we'll be sold, but the reading I do points that pharma and bio-pharma startups get the best returns on buyouts. Things are getting clearer in Canada about how pharma is getting involved.

Link:  https://www.theglobeandmail.com/canada/article-drug-companies-paid-nearly-75-million-to-doctors-health-care/ 

The real problem, and likely has something to do with the momentum killing selling Tetra has seen on their stock in 2018 JMHO.

Link:  https://www.thedailybeast.com/big-pharma-is-americas-new-mafia 

I have been hearing this quite frequesntly "buyout" by a big company. I have a few questions:

Do you know if Mgmt has enough shares to sway the verdict of an outcome for yes/no of Buyout?
Secondly, any speculations /feelers for buyout when it happens? This is all speculation assuming pp0001 phase3 will be success.

Thanks